These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The ability of insulin to inhibit the formation of amyloid by pro-islet amyloid polypeptide processing intermediates is significantly reduced in the presence of sulfated glycosaminoglycans. Wang H; Raleigh DP Biochemistry; 2014 Apr; 53(16):2605-14. PubMed ID: 24654599 [TBL] [Abstract][Full Text] [Related]
3. Amyloid formation by pro-islet amyloid polypeptide processing intermediates: examination of the role of protein heparan sulfate interactions and implications for islet amyloid formation in type 2 diabetes. Meng F; Abedini A; Song B; Raleigh DP Biochemistry; 2007 Oct; 46(43):12091-9. PubMed ID: 17924651 [TBL] [Abstract][Full Text] [Related]
4. Intracellular amyloid-like deposits contain unprocessed pro-islet amyloid polypeptide (proIAPP) in beta cells of transgenic mice overexpressing the gene for human IAPP and transplanted human islets. Paulsson JF; Andersson A; Westermark P; Westermark GT Diabetologia; 2006 Jun; 49(6):1237-46. PubMed ID: 16570161 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the heparin binding site in the N-terminus of human pro-islet amyloid polypeptide: implications for amyloid formation. Abedini A; Tracz SM; Cho JH; Raleigh DP Biochemistry; 2006 Aug; 45(30):9228-37. PubMed ID: 16866369 [TBL] [Abstract][Full Text] [Related]
6. Loss of prohormone convertase 2 promotes beta cell dysfunction in a rodent transplant model expressing human pro-islet amyloid polypeptide. Courtade JA; Wang EY; Yen P; Dai DL; Soukhatcheva G; Orban PC; Verchere CB Diabetologia; 2017 Mar; 60(3):453-463. PubMed ID: 27999871 [TBL] [Abstract][Full Text] [Related]
7. Processing of pro-islet amyloid polypeptide in the constitutive and regulated secretory pathways of beta cells. Marzban L; Trigo-Gonzalez G; Verchere CB Mol Endocrinol; 2005 Aug; 19(8):2154-63. PubMed ID: 15802374 [TBL] [Abstract][Full Text] [Related]
8. The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site. Wang J; Xu J; Finnerty J; Furuta M; Steiner DF; Verchere CB Diabetes; 2001 Mar; 50(3):534-9. PubMed ID: 11246872 [TBL] [Abstract][Full Text] [Related]
9. Processing of synthetic pro-islet amyloid polypeptide (proIAPP) 'amylin' by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro. Higham CE; Hull RL; Lawrie L; Shennan KI; Morris JF; Birch NP; Docherty K; Clark A Eur J Biochem; 2000 Aug; 267(16):4998-5004. PubMed ID: 10931181 [TBL] [Abstract][Full Text] [Related]
10. The sulfated triphenyl methane derivative acid fuchsin is a potent inhibitor of amyloid formation by human islet amyloid polypeptide and protects against the toxic effects of amyloid formation. Meng F; Abedini A; Plesner A; Middleton CT; Potter KJ; Zanni MT; Verchere CB; Raleigh DP J Mol Biol; 2010 Jul; 400(3):555-66. PubMed ID: 20452363 [TBL] [Abstract][Full Text] [Related]
11. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation. Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779 [TBL] [Abstract][Full Text] [Related]
12. Role of beta-cell prohormone convertase (PC)1/3 in processing of pro-islet amyloid polypeptide. Marzban L; Trigo-Gonzalez G; Zhu X; Rhodes CJ; Halban PA; Steiner DF; Verchere CB Diabetes; 2004 Jan; 53(1):141-8. PubMed ID: 14693708 [TBL] [Abstract][Full Text] [Related]
13. Hsp72 (HSPA1A) Prevents Human Islet Amyloid Polypeptide Aggregation and Toxicity: A New Approach for Type 2 Diabetes Treatment. Rosas PC; Nagaraja GM; Kaur P; Panossian A; Wickman G; Garcia LR; Al-Khamis FA; Asea AA PLoS One; 2016; 11(3):e0149409. PubMed ID: 26960140 [TBL] [Abstract][Full Text] [Related]
14. Role of carboxypeptidase E in processing of pro-islet amyloid polypeptide in {beta}-cells. Marzban L; Soukhatcheva G; Verchere CB Endocrinology; 2005 Apr; 146(4):1808-17. PubMed ID: 15618358 [TBL] [Abstract][Full Text] [Related]
15. Processing of pro-islet amyloid polypeptide (proIAPP) by the prohormone convertase PC2. Badman MK; Shennan KI; Jermany JL; Docherty K; Clark A FEBS Lett; 1996 Jan; 378(3):227-31. PubMed ID: 8557106 [TBL] [Abstract][Full Text] [Related]
16. Human pro-islet amyloid polypeptide (ProIAPP(1-48)) forms amyloid fibrils and amyloid spherulites in vitro. Exley C; House E; Patel T; Wu L; Fraser PE J Inorg Biochem; 2010 Oct; 104(10):1125-9. PubMed ID: 20579740 [TBL] [Abstract][Full Text] [Related]
17. Amyloidogenicity of recombinant human pro-islet amyloid polypeptide (ProIAPP). Krampert M; Bernhagen J; Schmucker J; Horn A; Schmauder A; Brunner H; Voelter W; Kapurniotu A Chem Biol; 2000 Nov; 7(11):855-71. PubMed ID: 11094339 [TBL] [Abstract][Full Text] [Related]
18. Substoichiometric Inhibition of Insulin against IAPP Aggregation Is Attenuated by the Incompletely Processed N-Terminus of proIAPP. Benhamou Goldfajn N; Tang H; Ding F ACS Chem Neurosci; 2022 Jul; 13(13):2006-2016. PubMed ID: 35704461 [TBL] [Abstract][Full Text] [Related]